Learn More
Medchemexpress LLC MASTL Kinase Inhibitor-1 | 1190277-80-5 | 98.1% | 302.33 | 50 MG

Supplier: Medchemexpress LLC HY13755250MG
MKI-1 is an inhibitor of MASTL (microtubule-associated serine/threonine kinase-like) with an IC50 of 9.9 μM. It exhibits antitumor and radiosensitizer activities through PP2A activation in breast cancer.
- Inhibits MASTL activity in breast cancer cells (5-20 μM)
- Inhibits oncogenic properties of breast cancer cells at 100 μM, with weaker effects on normal breast cells
- Reduces serine 62-phosphorylation of c-Myc and total c-Myc, with a decrease in ENSA phosphorylation
- Reduces c-Myc stability through PP2A activation in MCF7 cells
- Reduces tumor growth and enhances radiosensitivity in BT549 xenograft model (50 mg/kg, ip, twice a week)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.